Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 8, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 28
- −2 vs. Q4 2023
- Portfolio value
- $354.8M
- −$57.3M (−13.9%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MDTMedtronic plc | Stock | 411,893 | $35.9M | 10.1% | −23,182−5.3% | Reduced | History |
| PFEPfizer Inc | Stock | 1,239,165 | $34.4M | 9.7% | +145,749+13.3% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 498,536 | $27.0M | 7.6% | +123,849+33.1% | Added | History |
| CVSCVS Health Corp | Stock | 308,004 | $24.6M | 6.9% | +89,004+40.6% | Added | History |
| CAHCardinal Health Inc | Stock | 182,587 | $20.4M | 5.8% | +18,282+11.1% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 265,619 | $19.5M | 5.5% | −116,743−30.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 34,297 | $17.8M | 5.0% | +6,490+23.3% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 121,033 | $16.0M | 4.5% | −20,185−14.3% | Reduced | History |
| INCYIncyte Corp | COM | 264,895 | $15.1M | 4.3% | −133,804−33.6% | Reduced | History |
| BAXBaxter International Inc | Stock | 323,120 | $13.8M | 3.9% | −5,012−1.5% | Reduced | History |
| BIIBBiogen Inc. | COM | 59,698 | $12.9M | 3.6% | −42,536−41.6% | Reduced | History |
| UHSUniversal Health Services Inc | CL B | 69,881 | $12.8M | 3.6% | +69,881 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 33,662 | $11.6M | 3.3% | +10,053+42.6% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 123,133 | $11.2M | 3.2% | −124,398−50.3% | Reduced | History |
| BRKRBruker Corp | COM | 112,775 | $10.6M | 3.0% | −14,537−11.4% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 106,866 | $10.2M | 2.9% | −80,690−43.0% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 77,535 | $8.15M | 2.3% | −115,744−59.9% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 175,507 | $7.61M | 2.1% | +30,495+21.0% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 81,416 | $7.11M | 2.0% | −4,831−5.6% | Reduced | History |
| ALKSAlkermes plc. | SHS | 252,319 | $6.83M | 1.9% | +52,319+26.2% | Added | History |
| GMEDGlobus Medical Inc | Stock | 105,381 | $5.65M | 1.6% | −128,993−55.0% | Reduced | History |
| VTRSViatris Inc | Stock | 417,657 | $4.99M | 1.4% | +417,657 | New | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 164,378 | $4.81M | 1.4% | +164,378 | New | History |
| QGENQiagen N.V. | Stock | 103,369 | $4.44M | 1.3% | +103,369 | New | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 27,583 | $4.12M | 1.2% | −4,509−14.1% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 53,060 | $3.30M | 0.9% | +744+1.4% | Added | History |
| ILMNIllumina, Inc. | COM | 17,000 | $2.33M | 0.7% | −23,592−58.1% | Reduced | History |
| CNCCentene Corp | Stock | 22,216 | $1.74M | 0.5% | −194,200−89.7% | Reduced | History |
Sold out since Q4 2023 (6)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| LHLabcorp Holdings Inc. | COM NEW | 50,686 | $11.5M | 2.8% | History |
| QGENQiagen N.V. | SHS NEW | 190,539 | $8.28M | 2.0% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 188,111 | $5.89M | 1.4% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 102,490 | $4.90M | 1.2% | History |
| ABTAbbott Laboratories | Stock | 39,876 | $4.39M | 1.1% | History |
| VIRVir Biotechnology, Inc. | COM | 148,538 | $1.49M | 0.4% | History |